Physician profile
Robert Martinez
NPI 1285603480
$7,785.97
in general payments reported to CMS, 2019-2025
20 companies · $334 in 2025
The $334 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,224 · 2020: $721 · 2021: $2,287 · 2022: $78.57 · 2023: $387 · 2024: $1,754 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,386 · Travel and Lodging: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.47 |
| Travel and Lodging | $1,088.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,820.94 | 2019-2024 | |
| Lima USA, INC. | $1,405.50 | 2019-2020 | |
| Aesculap Implant Systems, LLC | $877.26 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $357.48 | 2022-2025 | Caplyta |
| Zimmer Biomet Holdings, INC. | $326.51 | 2019-2024 | Persona, Mymobility Platform |
| Stryker Corporation | $183.82 | 2022-2024 | Mako, Triathlon, Tritanium |
| Molnlycke Health Care US, LLC | $125.55 | 2024 | Mepilex Border Post-Op |
| Vertex Pharmaceuticals Incorporated | $125.00 | 2025 | |
| Ethicon US, LLC | $106.89 | 2020 | |
| Orthofix Medical, INC. | $105.35 | 2025 | Physio-Stim |
| Medtronic, INC. | $92.64 | 2021 | |
| Pacira Therapeutics, INC. | $89.79 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $33.64 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $24.07 | 2025 | Onivyde |
| Coastal Medical Technologies LLC | $23.36 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $21.40 | 2025 | Hetlioz, Fanapt |
| Horizon Therapeutics Plc | $19.55 | 2020 | |
| Lundbeck LLC | $19.53 | 2022 | |
| Abbott Laboratories | $16.30 | 2019 | |
| Fidia Pharma USA INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.